Announcement of the AMGEN Golden Ticket
Amgen and MBC BioLabs announced that BigHat Biosciences and Trilo Therapeutics have each been awarded an Amgen Golden Ticket to MBC BioLabs.
Symbiome Raises $15M for ‘Ancestral Microbiome’ Skin Range
Symbiome is slated to launch Oct. 7 with seven products that aim to shift the skin’s microbiome back to its “ancestral” state, according to Larry Weiss, founder and chief scientific officer.
How MBH Architects helped a critical research facility get built during the lockdown
Andres Grechi, Principal and Design Director at MBH Architects, talks about his insights on how his team helped complete a facility that may prove to be a game-changer in the fight against the COVID-19
MBC BioLabs partners with SPARK
The SPARK program at Stanford is a partnership between Stanford researchers and volunteer experts from the biotechnology ecosystem that provides education and mentorship.
Project Profile: MBC BioLab
Online Lab Manager introduces 930 Brittan Ave in San Carlos
XPose Therapeutics embarks on the discovery and development of novel oncology medicines targeting DNA Damage Response with non-dilutive funding from NCI
XPose Therapeutics is leveraging 3D structures of molecular fragments bound to drug targets to develop specific therapeutics.
Announcement of the 2020 Golden Ticket sponsored by Servier
2020 Servier Golden Ticket will be awarded in early September!
Biotech Startup Discovers Novel Hand Sanitizer for COVID-19, Offering Long-lasting 4+ Hours of Protection
IonLAST™, a novel hand sanitizer, kills germs on contact and, unlike common hand sanitizers, provides protection against their transmission for more than four hours after applying to skin.